12 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allegro-ophthalmics-receives-fda-agreement-under-special-protocol-assessment-spa-for-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd-301795701.html
03 Jan 2022
// Lee Han-soo KOREABIOMED
http://www.koreabiomed.com/news/articleView.html?idxno=12885